Concepedia

Publication | Open Access

Daprodustat for anemia: a 24-week, open-label, randomized controlled trial in participants with chronic kidney disease

DOIFull Paper Access

73

Citations

23

References

2018

Year

Louis Holdstock, Borut Čižman, Amy M. Meadowcroft, Nandita Biswas, Brendan M. Johnson, Delyth Jones, Sung Gyun Kim, Steven Zeig, John J. Lepore, Alexander R. Cobitz
Clinical Kidney Journal

Abstract

Daprodustat effectively maintained target hemoglobin over 24 weeks in CKD patients with anemia who were rhEPO naïve or had switched from existing rhEPO therapy.

References

YearCitations

Page 1